Refex Industries Limited (REFEX) — Board Meeting | 1 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
CARE Ratings confirms compliance with SEBI norms for Refex's preferential issue of shares and warrants.
🔄 What Changed
Rs. 19.07 crores reallocated from capital expenditure to working capital pending approval; Rs. 130.68 crores in warrants forfeited; Rs. 35 crores temporarily invested in inter-corporate deposit.
🔮 What's Next
Shareholder approval required for reallocation of reallocatedAmount; no explicit future funding plans disclosed.
💡 Investor Takeaway
The filing shows disciplined fund management with minor adjustments and no material risks, supporting confidence in capital allocation.

Refex Industries Limited received CARE Ratings' Monitoring Agency Report confirming compliance with SEBI regulations for its ₹220 crore preferential issue of shares and warrants. Funds of ₹62.50 crores were raised for equity and ₹157.19 crores for warrants, with ₹19.07 crores reallocated from capital expenditure to working capital pending shareholder approval. Lapsed warrants worth ₹130.68 crores were forfeited, and ₹35 crores were temporarily invested in an inter-corporate deposit. The report notes no deviations from fund utilization objectives and regulatory penalties involving promoter Anil Jain, with no material impact on fund deployment.

📄 View Original Announcement (PDF)

About Refex Industries Limited (REFEX)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹3,811.4 Cr P/E: 22.9

View full REFEX stock details →

📡 Get AI alerts when REFEX files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track REFEX — Free

📊 More REFEX filings

See all REFEX filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when REFEX files new disclosures

Track REFEX filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track REFEX — Free

Free account · 2 AI queries/day